Paloma Partners Management CO Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $8.2 Million - $9.02 Million	9,085 Added 4542.5%	9,285 $8.94 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $155,036 - $176,340	200 New	200 $175,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $140,006 - $166,070	-200 Reduced 40.0%	300 $215,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $340,245 - $413,485	500 New	500 $410,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.55 Million - $1.84 Million	2,700 Added 22.31%	14,800 $8.96 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $4.44 Million - $5.25 Million	9,400 Added 348.15%	12,100 $6.76 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $982,806 - $1.21 Million	2,200 Added 440.0%	2,700 $1.28 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $7.89 Million - $10 Million	-16,500 Reduced 97.06%	500 $242,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $1.37 Million - $1.88 Million	5,000 Added 41.67%	17,000 $6.38 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1.07 Million - $1.24 Million	3,900 Added 48.15%	12,000 $3.33 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $329,560 - $456,302	1,100 Added 15.71%	8,100 $2.54 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.38 Million - $1.63 Million	3,700 Added 112.12%	7,000 $2.87 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $4.7 Million - $5.64 Million	-14,000 Reduced 80.92%	3,300 $1.23 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $4.95 Million - $5.76 Million	14,100 Added 440.63%	17,300 $6.99 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $825,340 - $1 Million	-2,900 Reduced 47.54%	3,200 $1.1 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.8 Million - $2.24 Million	-5,700 Reduced 48.31%	6,100 $2.1 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $5.31 Million - $6.96 Million	-14,800 Reduced 55.64%	11,800 $4.44 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $11.5 Million - $13.4 Million	26,600	26,600 $11.9 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.37 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.8 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.63 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.05 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.83 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account